Featured Research

from universities, journals, and other organizations

Could a probiotic be used to treat inflammatory bowel disease?

Date:
October 20, 2011
Source:
University of Bristol
Summary:
A new study has found a scientific "design" for a probiotic that could be used to treat inflammatory bowel disease, such as Crohn's disease.

Scientists have been unclear for some time about how most probiotics work. A new study has found a scientific 'design' for a probiotic that could be used to treat inflammatory bowel disease (IBD), such as Crohn's disease.

The research by academics at the University of Bristol's School of Veterinary Sciences and School of Clinical Medicine is published online in the journal PLoS ONE.

Most probiotics on the market, such as Lactobacillus and Bifidobacterium, are lactic acid bacteria. Although probiotics have been shown to successfully maintain remission in IBD, evidence of their effectiveness in active disease is rare. The researchers have found that this is because an increase in iron levels, which happens during active IBD, inhibits the growth of probiotic bacteria, including Lactobacillus.

Iron levels increase in the intestine during inflammation, bleeding, during stress and when people are taking iron supplements. Iron is critically important to the growth of most species of bacteria, including pathogens, and its availability is what restricts their growth. It is well known that pathogens increase growth rate by up to 8,000 times when exposed to increased levels of iron. Lactic acid bacteria are unusual as they have evolved not to require iron, and so do not increase growth rate when exposed to it.

Dr Tristan Cogan, Research Fellow in the School of Veterinary Sciences, said: "When we started our study we considered the properties that a probiotic would need to treat IBD. Most importantly, it would need to be able to survive and grow in the presence of high levels of iron and to reduce inflammation. We then worked out how to test bacteria to see whether it had these properties.

"The difficult step was finding a bacterium that had all of the properties that we wanted. Now we have found something that looks like it should work, our next step will be to test the probiotic in clinical trials."

The researchers found that a range of probiotic strains of lactic acid bacteria cannot respond to increased iron levels. The study then identified a strain, which the academics have patented, that can and showed that it has probiotic and immunomodulatory properties, and can reduce pro-inflammatory responses to pathogens associated with IBD.

The researchers suggest that iron response is the factor that prevents probiotics from being useful in treating disease, and that their bacterium could be a novel probiotic treatment for active intestinal disease.


Story Source:

The above story is based on materials provided by University of Bristol. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jennifer R. Bailey, Christopher S. J. Probert, Tristan A. Cogan. Identification and Characterisation of an Iron-Responsive Candidate Probiotic. PLoS ONE, 2011; 6 (10): e26507 DOI: 10.1371/journal.pone.0026507

Cite This Page:

University of Bristol. "Could a probiotic be used to treat inflammatory bowel disease?." ScienceDaily. ScienceDaily, 20 October 2011. <www.sciencedaily.com/releases/2011/10/111020024716.htm>.
University of Bristol. (2011, October 20). Could a probiotic be used to treat inflammatory bowel disease?. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/10/111020024716.htm
University of Bristol. "Could a probiotic be used to treat inflammatory bowel disease?." ScienceDaily. www.sciencedaily.com/releases/2011/10/111020024716.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins